Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul B Mehta

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Heart (British Cardiac Society)|September 6, 2011
Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease surveyPerry Elliott, Robert Baker, Ferdinando Pasquale, et al.
European Journal of Haematology|August 18, 2005
Haemorheology in Gaucher diseaseBridget E Bax, Linda Richfield, Murray D Bain, et al.
The American Journal of Cardiology|September 20, 2005
Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry diseaseJaymin S Shah, Derralynn A Hughes, Bhavesh Sachdev, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 30, 2020
Assessment of plasma lyso-Gb<sub>3</sub> for clinical monitoring of treatment response in migalastat-treated patients with Fabry diseaseDaniel G Bichet, Johannes M Aerts, Christiane Auray-Blais, et al.
Haematologica|November 11, 2003
V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemiaVeronique M Duke, Domenica Gandini, Paul D Sherrington, et al.
British Journal of Haematology|June 5, 2003
Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligandDylan T Jones, Kanagasabai Ganeshaguru, Wayne A Mitchell, et al.
Blood|October 25, 2003
Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugsDylan T Jones, Elena Addison, Janet M North, et al.
Haematologica|July 20, 2004
Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabineGareth Gerrard, Elspeth Payne, Robert J Baker, et al.
Blood|December 14, 2002
Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosisDylan T Jones, Kanagasabai Ganeshaguru, Robert J Anderson, et al.
Cancer Research|March 23, 2005
Selective apoptotic killing of malignant hemopoietic cells by antibody-targeted delivery of an amphipathic peptideAlexandra J Marks, Margaret S Cooper, Robert J Anderson, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Heart (British Cardiac Society)|September 6, 2011
Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease surveyPerry Elliott, Robert Baker, Ferdinando Pasquale, et al.
European Journal of Haematology|August 18, 2005
Haemorheology in Gaucher diseaseBridget E Bax, Linda Richfield, Murray D Bain, et al.
The American Journal of Cardiology|September 20, 2005
Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry diseaseJaymin S Shah, Derralynn A Hughes, Bhavesh Sachdev, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 30, 2020
Assessment of plasma lyso-Gb<sub>3</sub> for clinical monitoring of treatment response in migalastat-treated patients with Fabry diseaseDaniel G Bichet, Johannes M Aerts, Christiane Auray-Blais, et al.
Haematologica|November 11, 2003
V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemiaVeronique M Duke, Domenica Gandini, Paul D Sherrington, et al.
British Journal of Haematology|June 5, 2003
Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligandDylan T Jones, Kanagasabai Ganeshaguru, Wayne A Mitchell, et al.
Blood|October 25, 2003
Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugsDylan T Jones, Elena Addison, Janet M North, et al.
Haematologica|July 20, 2004
Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabineGareth Gerrard, Elspeth Payne, Robert J Baker, et al.
Blood|December 14, 2002
Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosisDylan T Jones, Kanagasabai Ganeshaguru, Robert J Anderson, et al.
Cancer Research|March 23, 2005
Selective apoptotic killing of malignant hemopoietic cells by antibody-targeted delivery of an amphipathic peptideAlexandra J Marks, Margaret S Cooper, Robert J Anderson, et al.
Pageof 3